I posted here the other day that we received amy dad‘s testing from Guardant. It showed high RYP amplification. It also showed .02% BRACA mutation. His regular MO recommends getting into a phase 1 for the RYP amplification.
Yesterday we had a phone consultation with Dr. Lam at Prostate Oncology. Dr. Lam was excited by the very BRACA mutation and recommended Lynparza. My dad‘s regular MSO thinks this is ridiculous suggestion and refuses to prescribe it.
Again I am racing the clock and feel completely stuck.
Written by
Damusolf
To view profiles and participate in discussions please or .
He has a microscopic amount of BRCA2 mutation, so I agree with his MO that Lynparza would be a very poor choice at this time. It is very toxic and would have no benefit. I'm frankly surprised that Dr Lam would advocate it. On the other hand, he has high RYP amplification and a clinical trial to address it. His MO sounds terrific!
While Lynparza would be foolish now, genetic breakdown continues over time, so you can do another Guardant analysis after the trial to see if there might be any benefit to it later.
Regarding Lynparza trials that will pay for this drug, UC Davis Sacramento has one. Trial number NCT02893917. Must have a tumor that can be biopsied again. Mutation not required to qualify because it is tested with another drug together.
We have a consult with another MO for another opinion in the morning. I’m hopeful we’ll both find something hat will fight the cancer. I’m I’m ordering the BIRM that nalakrats suggests. I’m using several other natural supplements to help with the anemia caused by Radium 223. Keep us all posted if you get news.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.